πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7943131

Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

GENERAL REGENERATIVES, LTD. Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7927583

Receptor based antagonists and methods of making and using

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910621

Small molecule antagonists of XIAP family proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910608

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902220

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902221

Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884091

Methods for treating delirium using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879838

Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7875637

Benzimidazole derivative and use as a II receptor antagonist

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868006

Heterocyclic substituted piperazines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7868175

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858795

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858797

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858792

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855202

Imidazopyridine derivatives as A2B adenosine receptor antagonists

Laboratories Almirall, S.A. Β· Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851632

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851631

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7850961

Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor anta

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842704

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7842686

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838535

Compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activit

Theravance, Inc. Β· Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7834185

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7834000

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820154

Use of IL-1 antagonists to treat gout

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted